EBS EBITDA Growth
Emergent Biosolutions Inc · EBITDA Growth
EBS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-100.26%period ending
EBS TTM EBITDA YoY % (105.66% → -100.26%)
Year-over-year change
High-resolution chart · PNG
EBS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -100.2552% | |
| 25.1022% | |
| 342.1933% | |
| 1,295.3846% | |
| 603.3028% | |
| -2.16% | |
| 227.1868% | |
| 119.1011% | |
| -94.6429% | |
| 216.9317% | |
| -224.7788% | |
| -97.412% | |
| -107.8807% | |
| -124.6143% | |
| -93.502% | |
| -25.3203% | |
| -38.8152% | |
| -36.7186% | |
| -9.7873% | |
| 15.2979% | |
| 53.3404% | |
| 179.4381% | |
| 153.863% | |
| 144.7394% | |
| 284.4904% | |
| 57.2404% | |
| 42.7372% | |
| -13.1554% | |
| -53.6904% | |
| 2.6606% | |
| -8.7106% | |
| 10.8336% | |
| 32.3596% | |
| 2.169% | |
| 13.3463% | |
| -1.2804% | |
| -17.1088% | |
| -36.8065% | |
| -17.3772% | |
| 5.292% | |
| 47.5095% | |
| 137.9015% | |
| 88.5216% | |
| 117.9183% | |
| 126.0022% | |
| 63.0545% | |
| 41.9188% | |
| 29.9406% | |
| 24.0671% | |
| 51.5958% | |
| 74.546% | |
| -9.4519% | |
| -14.6424% | |
| -38.5901% | |
| -3.22% | |
| 111.5982% | |
| 13.912% | |
| 59.4736% | |
| -47.7231% | |
| -37.1945% | |
| 105.0842% | |
| 25.6456% | |
| 69.8519% | |
| 11.3878% | |
| -61.2548% | |
| -20.1926% | |
| 33.2484% | |
| -44.1993% | |
| -8.2268% | |
| -24.6881% | |
| -4.732% | |
| 104.7508% | |
| 52.338% | |
| -25.6348% | |
| -63.1507% | |
| 149.0235% | |
| 28.0953% | |
| 78.1772% | |
| 107.5534% | |
| -59.4301% | |
| 16.2497% | |
| 94.303% | |
| 269.8911% | |
| 1,602.502% | |
| 150.1947% | |
| 105.6602% |